UCB — Board/Management Information 2022

Mar 25, 2022

Kay DAVIES

Independent Director Member of the Board since 2014 Member of the Scientific Committee since 2014 Member of the Governance, Nomination and Compensation Committee since 2017 Date of birth: 1951 Nationality: British Gender: Female End of term: 2022

Introduction & Professional experience

Kay Davies is Dr Lee's Professor of Anatomy Emeritus and co-Director of the Muscular Dystrophy UK Oxford Neuromuscular Centre in the Department of Physiology, Anatomy and Genetics at the University of Oxford.

Her research interests lie in the molecular analysis and development of treatment for human genetic disease, particularly, Duchenne muscular dystrophy (DMD) and the application of genomics for the analysis of neurological disorders. She has published more than 400 papers and won numerous awards for her work. She is co-founder of Summit Therapeutics (novel antibiotics) and Oxstem (stem cells for disease therapy). She is a founding fellow of the UK Academy of Medical Sciences and was elected a Fellow of the Royal Society in 2003. She is a Director of Oxford Biomedica plc and of Genome Research Ltd. She served as a Governor of the Wellcome Trust 2008-2017 and as Deputy Chair from 2013-2017.

Professor Davies was made Dame Commander of the British Empire for services to science in 2008. She has also been involved as independent scientific advisor on UCB's Science Advisory Board since 2012 and is a member of the UCB's Governance, Nomination and Compensation Committee ("GNCC") as from 2017.

Education

BA PhD – University of Oxford

Main external appointments

Member of the Board of Directors of Oxford Biomedica* Member of the Scientific Advisory Board of Sarepta Therapeutics Director of Genome Research Ltd * Listed company